August 8, 2011

Did you Purchase Stock in Dendren Corporation (DNDN)?

Securities attorney, Lars Soreide, of Soreide Law Group, PLLC, is currently investigating the Dendreon Corp. (NASDAQ: DNDN) for possible violations of federal securities laws after the company’s withdrawal of its sales forecasts for its prostate cancer therapy Provenge. Dendreon projected that it would earn between $350 - $400 million on sales of Provenge.

The Dendreon Corporation is a Seattle-based biotechnology company focused on the discovery, development and commercialization of novel therapeutics that may improve cancer treatment options for patients.

With the announcement of Dendreon withdrawing it's earnings guidance, the stock fell from a closing price on August 3, 2011 of $33.65 to an opening price on August 4, 2011 of $12.73. The shares of DNDN fell more than 60 percent after the company withdrew its 2011 revenue estimates allegedly costing the company $3.2 billion in market value.  Today, it is at $11.05.

If you or a family member  invested in DNDN stock and suffered losses, call a Securities Arbitration Lawyer for a free consultation on how to potentially recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.securitieslawyer.com.

Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

S H A R E   T H I S   P O S T

Recent Posts

May 16, 2026
George Portilla Linked To Equitable Advisors Client’s Arbitration Claim About Unsuitable Advice

Investors might have sustained losses due to securities broker George Portilla (also known as Jorge Portilla) [CRD: 2222382, Miami Lakes, Florida], given the public information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Portilla worked for Equitable Advisors LLC from March 31, 1992, to March 9, 2021. See below to discover more about the disclosures involving […]

May 16, 2026
David Olsen Linked To Madison Avenue Securities Investor’s Unsuitable Advice Arbitration Claim

Investors potentially experienced sales practice violations by securities broker David Thomas Olsen [CRD: 4823650, Fort Lauderdale, Florida], given the disclosures located on Financial Industry Regulatory Authority (FINRA) BrokerCheck. David Olsen worked for Madison Avenue Securities LLC from October 31, 2017, to December 8, 2023, and again from January 8, 2025, to December 31, 2025. See […]

May 16, 2026
Stephen Wiedemann Linked To Wells Fargo Investor Arbitration Claim Re: Unsuitable Advice

Investors potentially incurred losses because of securities broker Stephen Wiedemann [CRD: 2212349, Newport Beach, California], based on publicly available information found on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Wiedemann worked for Wells Fargo Clearing Services LLC and Wells Fargo Advisors beginning on August 31, 2018, in Newport Beach, California. Investors are encouraged to continue reading […]

Copyright © 2025 Soreide Law Group, PLLC  |  All Rights Reserved